Compare MYNZ & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYNZ | CHNR |
|---|---|---|
| Founded | 2021 | N/A |
| Country | Germany | China |
| Employees | 26 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 4.7M |
| IPO Year | 2021 | 1995 |
| Metric | MYNZ | CHNR |
|---|---|---|
| Price | $1.04 | $3.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 305.7K | 19.1K |
| Earning Date | 12-29-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $659,935.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $3.16 |
| 52 Week High | $8.20 | $8.20 |
| Indicator | MYNZ | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 45.79 |
| Support Level | $1.00 | $3.75 |
| Resistance Level | $1.15 | $4.31 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 37.04 | 43.35 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.